Exhibit 10.4
EXECUTION COPY
STOCK PURCHASE
AGREEMENT
by and among
HHC RIVER PARK,
INC.
as Purchaser,
SCOTT C. STAMM AND PATRICK D.
BURROWS
as the
Shareholders
and
PSYCHMANAGEMENT GROUP,
INC.
Dated as of June 9,
2005
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page No.
|
|
ARTICLE 1 DEFINITIONS;
SALE AND TRANSFER OF SHARES; CONSIDERATION; CLOSING
|
|
1
|
|
1.1
|
|
Definitions
|
|
1
|
|
1.2
|
|
Agreement to Sell and Purchase
|
|
2
|
|
1.3
|
|
Purchase Price
|
|
3
|
|
1.4
|
|
Closing Date
|
|
3
|
|
1.5
|
|
Items to be Delivered by Shareholders at
Closing
|
|
3
|
|
1.6
|
|
Items to be Delivered by Purchaser at
Closing
|
|
4
|
|
1.7
|
|
Termination of Mountain State Management
Agreement
|
|
5
|
|
1.8
|
|
Variable Payments A and B
|
|
6
|
|
1.9
|
|
Variable Payments C and D
|
|
7
|
|
1.10
|
|
Net Assets Settlement
|
|
8
|
|
|
|
|
ARTICLE
2 REPRESENTATIONS AND WARRANTIES OF THE
SHAREHOLDERS
|
|
10
|
|
2.1
|
|
Authority
|
|
10
|
|
2.2
|
|
Authorization/Execution
|
|
10
|
|
2.3
|
|
Organization and Good Standing; No
Subsidiaries; No Conflicts
|
|
10
|
|
2.4
|
|
Title to Shares
|
|
11
|
|
2.5
|
|
Financial Statements; Changes
|
|
11
|
|
2.6
|
|
Tax and Other Returns and Reports
|
|
12
|
|
2.7
|
|
Contracts
|
|
14
|
|
2.8
|
|
Real and Personal Property; Title to Property;
Leases
|
|
15
|
|
2.9
|
|
Capitalization of the Company
|
|
15
|
|
2.10
|
|
Intangible Property
|
|
16
|
|
2.11
|
|
Legal Proceedings
|
|
16
|
|
2.12
|
|
Accounting Records; Internal
Controls
|
|
16
|
|
2.13
|
|
Insurance
|
|
16
|
|
2.14
|
|
Employees
|
|
17
|
|
2.15
|
|
Employee Benefits
|
|
17
|
|
2.16
|
|
Certain Interests
|
|
18
|
|
2.17
|
|
Intercompany Transactions
|
|
18
|
|
2.18
|
|
Inventory
|
|
18
|
|
2.19
|
|
Receivables
|
|
18
|
|
2.20
|
|
Third Party Payors and Suppliers
|
|
18
|
|
2.21
|
|
Worker Adjustment and Retraining Notification
(WARN)
|
|
18
|
|
2.22
|
|
Environmental Compliance
|
|
19
|
|
2.23
|
|
Powers of Attorney
|
|
19
|
|
2.24
|
|
Medicare and Medicaid; Third-Party Payors;
Compliance with Health Care Laws
|
|
19
|
|
2.25
|
|
HIPAA
|
|
20
|
|
2.26
|
|
Solvency
|
|
20
|
|
2.27
|
|
No Brokers or Finders
|
|
20
|
- i -
|
|
|
|
|
|
|
2.28
|
|
No Misrepresentations
|
|
21
|
|
2.29
|
|
Improper Payments
|
|
21
|
|
2.30
|
|
No Undisclosed Liabilities
|
|
21
|
|
2.31
|
|
No Other Representations or
Warranties
|
|
21
|
|
|
|
|
ARTICLE
3 REPRESENTATIONS AND WARRANTIES OF
PURCHASER
|
|
21
|
|
3.1
|
|
Authority
|
|
21
|
|
3.2
|
|
Authorization/Execution
|
|
21
|
|
3.3
|
|
Organization and Good Standing; No
Violation
|
|
22
|
|
3.4
|
|
Legal Proceedings
|
|
22
|
|
3.5
|
|
Solvency
|
|
22
|
|
3.6
|
|
No Conflicts; Consents
|
|
22
|
|
3.7
|
|
Availability of Funds; Performance of
Obligations
|
|
23
|
|
3.8
|
|
Brokers and Finders
|
|
23
|
|
|
|
|
ARTICLE 4 COVENANTS OF
THE SHAREHOLDERS
|
|
23
|
|
4.1
|
|
Access and Information; Inspection Period,
Preparation of Exhibits and Disclosure Schedules
|
|
23
|
|
4.2
|
|
Conduct of Business
|
|
23
|
|
4.3
|
|
Negative Covenants
|
|
24
|
|
4.4
|
|
Consents
|
|
24
|
|
4.5
|
|
Additional Financial Information
|
|
25
|
|
4.6
|
|
No-Shop
|
|
25
|
|
4.7
|
|
Shareholders’ Efforts to Close
|
|
25
|
|
4.8
|
|
Updating of Disclosure Schedules
|
|
25
|
|
4.9
|
|
Code Section 338(h)(10) Election
|
|
26
|
|
4.10
|
|
S Corporation Status
|
|
26
|
|
|
|
|
ARTICLE 5 COVENANTS OF
PURCHASER
|
|
26
|
|
5.1
|
|
Purchaser’s Efforts to Close
|
|
26
|
|
5.2
|
|
Required Governmental Approvals
|
|
26
|
|
5.3
|
|
Confidentiality
|
|
27
|
|
5.4
|
|
Enforceability
|
|
27
|
|
5.5
|
|
Waiver of Bulk Sales Law Compliance
|
|
27
|
|
|
|
|
ARTICLE 6 CONDITIONS
PRECEDENT TO OBLIGATIONS OF SHAREHOLDERS
|
|
28
|
|
6.1
|
|
Accuracy of Representations and Warranties and
Compliance with Obligations
|
|
28
|
|
6.2
|
|
Signing and Delivery of Instruments
|
|
28
|
|
6.3
|
|
Unfavorable Action or Proceeding
|
|
28
|
|
6.4
|
|
Governmental Authorizations
|
|
28
|
|
|
|
|
ARTICLE 7 CONDITIONS
PRECEDENT TO OBLIGATIONS OF PURCHASER
|
|
28
|
|
7.1
|
|
Accuracy of Representations and Warranties and
Compliance with Obligations
|
|
29
|
|
7.2
|
|
Governmental Authorizations
|
|
29
|
|
7.3
|
|
Signing and Delivery of Instruments
|
|
29
|
|
7.4
|
|
Unfavorable Action or Proceeding
|
|
29
|
- ii -
|
|
|
|
|
|
|
7.5
|
|
No Material Adverse Change
|
|
29
|
|
7.6
|
|
Required Consents
|
|
29
|
|
7.7
|
|
Disclosure Schedules
|
|
29
|
|
7.8
|
|
Asset Purchase Agreement
|
|
29
|
|
7.9
|
|
Termination of Plans
|
|
29
|
|
7.10
|
|
Amendment of Split-Dollar Agreements
|
|
30
|
|
|
|
|
ARTICLE
8 TERMINATION
|
|
30
|
|
8.1
|
|
Termination
|
|
30
|
|
8.2
|
|
Termination Consequences
|
|
31
|
|
|
|
|
ARTICLE 9 POST-CLOSING
MATTERS
|
|
31
|
|
9.1
|
|
Preservation and Access to Records After the
Closing
|
|
31
|
|
9.2
|
|
Provision of Benefits of Certain
Contracts
|
|
31
|
|
9.3
|
|
Employee Matters
|
|
32
|
|
9.4
|
|
Post-Closing Operations of the
Company
|
|
32
|
|
9.5
|
|
Certain Employee Matters
|
|
32
|
|
9.6
|
|
Payment of Premiums
|
|
33
|
|
|
|
|
ARTICLE 10 SURVIVAL AND
INDEMNIFICATION
|
|
33
|
|
10.1
|
|
Survival
|
|
33
|
|
10.2
|
|
Indemnification of Purchaser by
Shareholders
|
|
33
|
|
10.3
|
|
Indemnification of Shareholders by
Purchaser
|
|
35
|
|
10.4
|
|
Method of Asserting Claims
|
|
36
|
|
10.5
|
|
Right of Offset
|
|
38
|
|
10.6
|
|
Exclusive Remedy
|
|
39
|
|
|
|
|
ARTICLE 11 TAX AND COST
REPORT MATTERS
|
|
39
|
|
11.1
|
|
Tax Matters
|
|
39
|
|
|
|
|
ARTICLE 12 MISCELLANEOUS
PROVISIONS
|
|
40
|
|
12.1
|
|
Entire Agreement
|
|
40
|
|
12.2
|
|
Further Assurances and Cooperation
|
|
40
|
|
12.3
|
|
Successors and Assigns
|
|
40
|
|
12.4
|
|
Governing Law
|
|
40
|
|
12.5
|
|
Amendments
|
|
40
|
|
12.6
|
|
Notices
|
|
41
|
|
12.7
|
|
Headings
|
|
41
|
|
12.8
|
|
Confidentiality and Publicity
|
|
42
|
|
12.9
|
|
Third Party Beneficiary
|
|
42
|
|
12.10
|
|
Expenses and Attorneys’ Fees
|
|
42
|
|
12.11
|
|
No Waiver
|
|
42
|
|
12.12
|
|
Severability
|
|
42
|
|
12.13
|
|
Counterparts
|
|
43
|
- iii -
LIST OF EXHIBITS
|
|
|
|
|
EXHIBIT
|
|
DESCRIPTION
|
|
|
|
|
A
|
|
Post-Closing
Escrow Agreement
|
|
|
|
|
B
|
|
Guaranty and
Suretyship
|
- 1 -
LIST OF SCHEDULES
|
|
|
|
|
SCHEDULE
|
|
DESCRIPTION
|
|
1.5(g)
|
|
Consents to
Company Change in Control
|
|
1.8
|
|
Provisions
Relating to Contribution to EBITDA
|
|
2.3(c)
|
|
Company/Shareholder Consents and
Conflicts
|
|
2.5(a)
|
|
Financial
Statement Matters
|
|
2.5(c)
|
|
Changes Since
Interim Balance Sheet Date
|
|
2.6
|
|
Tax
Matters
|
|
2.7
|
|
Contracts
|
|
2.8
|
|
Listing of
Assets
|
|
2.10
|
|
Intangible
Property
|
|
2.11
|
|
Litigation
|
|
2.13
|
|
Insurance/Claims
|
|
2.14
|
|
Employees
|
|
2.15
|
|
Employee
Benefits
|
|
2.16
|
|
Certain
Interests
|
|
2.17
|
|
Intercompany
Transaction
|
|
2.20
|
|
Payor
Contracts
|
|
2.23
|
|
Powers of
Attorney
|
|
2.24
|
|
Medicare/Medicaid Compliance
|
|
2.30
|
|
Indebtedness
|
|
3.6
|
|
Purchaser’s Conflicts and
Consents
|
|
10.2(a)
|
|
Certain
Indemnification Matters
|
|
11.1(b)
|
|
Allocation of
Purchase Price
|
- 1 -
TABLE OF DEFINED
TERMS
|
|
|
|
|
Term
|
|
Page
|
|
Acceleration Event
|
|
Schedule 1.8
|
|
Accounting Firm
|
|
7
|
|
Additional Contract
|
|
8
|
|
Affiliate
|
|
2
|
|
Agreement
|
|
1
|
|
Articles
|
|
1
|
|
Asset Purchase Agreement
|
|
4
|
|
Claim Notice
|
|
36
|
|
Closing
|
|
3
|
|
Closing Date
|
|
3
|
|
Closing Purchase Price Payment
|
|
3
|
|
COBRA Coverage
|
|
33
|
|
Code
|
|
13
|
|
Code Section 338(h)(10) Election
|
|
26
|
|
Commonly Controlled Entity
|
|
18
|
|
Company
|
|
1
|
|
Company Historical GAAP
|
|
6
|
|
Confidential Information
|
|
27
|
|
Contract
|
|
14
|
|
Contract Consents
|
|
4
|
|
Contribution to EBITDA
|
|
6
|
|
Control
|
|
2
|
|
Damages
|
|
33
|
|
Disclosure Schedules
|
|
2
|
|
Document Retention Period
|
|
31
|
|
Earn-Out Period
|
|
Schedule 1.8
|
|
Effective Time
|
|
3
|
|
Encumbrances
|
|
2
|
|
Environmental Laws
|
|
19
|
|
ERISA
|
|
17
|
|
Escrow Agreement
|
|
3
|
|
ESL
|
|
17
|
|
Estimated Net Assets
|
|
9
|
|
Execution Date
|
|
1
|
|
First Variable Payment Date
|
|
5
|
|
GAAP
|
|
6
|
|
Governmental Approvals
|
|
4
|
|
HIPAA
|
|
20
|
|
Hired Employee
|
|
32
|
- 1 -
|
|
|
|
|
Indemnified Party
|
|
35
|
|
Indemnifying Party
|
|
36
|
|
Indemnity Notice
|
|
37
|
|
Individually Identifiable Health
Information
|
|
27
|
|
Intangible Property
|
|
16
|
|
Interim Balance Sheet Date
|
|
11
|
|
Knowledge of Purchaser
|
|
2
|
|
Knowledge of the Shareholders
|
|
2
|
|
Material Adverse Change
|
|
2
|
|
Material Adverse Effect
|
|
2
|
|
Mountain State
|
|
5
|
|
Mountain State Management Agreement
|
|
5
|
|
Net Assets
|
|
8
|
|
Net Assets Payment
|
|
9
|
|
Notice Period
|
|
36
|
|
Parent Guaranty
|
|
5
|
|
Parties
|
|
1
|
|
Party
|
|
1
|
|
Permitted Encumbrances
|
|
16
|
|
Person
|
|
2
|
|
Plan
|
|
17
|
|
Purchase Price
|
|
2
|
|
Purchaser
|
|
1
|
|
Relevant Claim
|
|
34
|
|
Second Variable Payment Date
|
|
6
|
|
Sections
|
|
1
|
|
SERP
|
|
29
|
|
Shareholder
|
|
1
|
|
Shares
|
|
1
|
|
Split-Dollar Agreements
|
|
30
|
|
Subsidiaries
|
|
12
|
|
Subsidiary
|
|
12
|
|
Superseded Agreements
|
|
40
|
|
Tax
|
|
14
|
|
Tax Claims
|
|
34
|
|
Taxes
|
|
14
|
|
Third Party Claim
|
|
36
|
|
Variable Payment A
|
|
5
|
|
Variable Payment B
|
|
6
|
|
Variable Payment C
|
|
7
|
|
Variable Payment D
|
|
7
|
|
WARN Act
|
|
18
|
|
Year 1 Additional Contract Contribution
Target
|
|
7
|
|
Year 1 Existing Contract EBITDA
Target
|
|
6
|
|
Year 2 Additional Contract Contribution
Target
|
|
8
|
|
Year 2 Existing Contract EBITDA
Target
|
|
6
|
- 2 -
STOCK PURCHASE
AGREEMENT
This STOCK PURCHASE AGREEMENT (this
“Agreement”) is made and entered into as of the
9 th day of June, 2005 (the
“Execution Date”) by and between SCOTT C. STAMM AND
PATRICK D. BURROWS (each a “Shareholder” and
collectively, the “Shareholders”), HHC RIVER PARK,
INC. , a West Virginia corporation (“Purchaser”)
and PSYCHMANAGEMENT GROUP, INC. , a West Virginia
corporation (the “Company”). The Shareholders, the
Company and Purchaser are sometimes collectively referred to herein
as the “Parties” and individually referred to herein as
a “Party.”
RECITALS:
A. The Shareholders collectively own
One Thousand (1,000) shares of Common Stock, $1.00 par value, of
the Company (collectively, the “Shares”), and the
Shares constitute all the issued and outstanding capital stock of
the Company; and
B. Purchaser desires to purchase the
Shares from the Shareholders, and the Shareholders desire to sell
the Shares to Purchaser, for the consideration and upon the terms
and conditions contained in this Agreement.
AGREEMENT:
NOW, THEREFORE, in consideration of
the foregoing premises and the mutual promises and covenants
contained in this Agreement, the Parties hereto agree as
follows:
ARTICLE 1
DEFINITIONS; SALE AND TRANSFER OF
SHARES;
CONSIDERATION;
CLOSING
1.1 Definitions . For all
purposes of this Agreement, except as otherwise expressly provided
or unless the context otherwise requires,
(a) The defined terms used in this
Agreement shall include the plural as well as the
singular.
(b) All accounting terms not
otherwise defined herein have the meanings assigned under
GAAP.
(c) All references in this Agreement
to designated “Articles,” “Sections” and
other subdivisions are to the designated Articles, Sections and
other subdivisions of the body of this Agreement.
(d) Pronouns of either gender or
neuter shall include, as appropriate, the other pronoun
forms.
(e) The words
“including” and “include” shall be deemed
to mean in each instance “including, without
limitation,” except as stated otherwise herein.
STOCK PURCHASE
AGREEMENT – Page
1
(f) The words “herein,”
“hereof” and “hereunder” and other words of
similar import refer to this Agreement as a whole, including the
Exhibits and Schedules attached hereto, and not to any particular
Article, Section or other subdivision.
(g) “Disclosure
Schedules” shall mean the schedules attached to and
constituting a part of this Agreement.
(h) “Knowledge of
Purchaser,” and similar variations thereof, shall mean the
actual knowledge, as of the relevant date, of Donald Thayer, Peter
Kavanaugh, Dave White, Tony Vadella, David Meyercord or Matt
Lisagor after reasonable inquiry of employees or agents of
Purchaser that were involved in its due diligence review of the
Shareholders and the Company.
(i) “Knowledge of the
Shareholders,” and similar variations thereof, shall mean the
actual knowledge, as of the relevant date, of Scott C. Stamm or
Patrick D. Burrows after reasonable inquiry of all employees of the
Company responsible for the relevant matters.
(j) “Material Adverse
Change” or “Material Adverse Effect,” when used
with respect to the Company, shall mean any material adverse change
in or effect on the Company taken as a whole, other than changes or
effects that are or result from occurrences relating to the United
States economy generally or the United States health care industry
generally.
(k) Any reference in this Agreement
to an “Affiliate” shall mean any Person directly or
indirectly controlling, controlled by or under common control with
a second Person. The term “Control” (including the
terms “controlled by” and “under common control
with”) means the possession, direct or indirect, of the power
to direct or cause the direction of the management and policies of
a Person, whether through the ownership of voting securities, by
contract or otherwise. A “Person” shall mean any
natural person, partnership, corporation, limited liability
company, association, trust or other legal entity.
Capitalized terms used in this
Agreement shall have the definitions assigned to such terms
elsewhere in this Agreement. For ease of reference, the section
containing the definition of each such capitalized term is set
forth in the table of defined terms included elsewhere as a part of
this Agreement.
1.2 Agreement to Sell and
Purchase . Subject to the terms and conditions of this
Agreement and in reliance on the representations, warranties and
covenants herein set forth, at the Closing the Shareholders shall
sell to Purchaser, and Purchaser shall purchase from the
Shareholders, the Shares, free and clear of any and all liens,
claims, options, charges, pledges, security interests, voting
agreements or trusts, proxies, preemptive rights, rights of first
refusal, encumbrances or other restrictions or interests of any
kind or nature whatsoever (collectively,
“Encumbrances”).
STOCK PURCHASE
AGREEMENT – Page
2
1.3 Purchase Price . Subject
to the terms and conditions of this Agreement, the aggregate
purchase price to be paid by Purchaser to the Shareholders for the
purchase of the Shares (the “Purchase Price”) shall
consist of:
(a) Three Million Three Hundred
Sixty-five Thousand and 00/100 Dollars ($3,365,000.00) (the
“Closing Purchase Price Payment”) which shall be
payable in cash at the Closing;
(b) The Net Assets Payment, which
shall be the payment delivered as set forth in Section 1.10 and
shall, as applicable, be added to or be deducted from the Closing
Purchase Price Payment at Closing, as set forth in Section
1.10;
(c) Variable Payment A described in
Section 1.8(a);
(d) Variable Payment B described in
Section 1.8(b);
(e) Variable Payment C described in
Section 1.9(a); and
(f) Variable Payment D described in
Section 1.9(b).
1.4 Closing Date . The
consummation of the transactions contemplated by this Agreement
(the “Closing”) shall take place at 10:00 a.m. at the
offices of Strasburger & Price, L.L.P., located at 901 Main
Street, Suite 4300, Dallas, Texas, on or before five (5) business
days after all conditions precedent and other matters required to
be completed as of the Closing Date have been or will be completed
on such date or such other date, time and place as the Parties
shall mutually agree (the “Closing Date”). The Closing
with respect to the transfer of the Shares, shall be deemed to have
occurred and to be effective as between the Parties as of 12:01
a.m., Eastern Daylight Time, on the Closing Date (the
“Effective Time”).
1.5 Items to be Delivered by
Shareholders at Closing . At or before the Closing, the
Shareholders shall deliver to Purchaser the following, duly
executed by the Shareholders (and/or the Company) where appropriate
and in the form attached hereto as an Exhibit:
(a) The original certificates
representing the Shares, duly endorsed for immediate transfer, or
with appropriate stock powers with respect thereto, duly endorsed
in blank by the Shareholders;
(b) Post-Closing Escrow Agreement in
the form of Exhibit A attached hereto (the “Escrow
Agreement”);
(c) original certificates of good
standing, or comparable status, of the Company, issued by the State
of West Virginia, dated no earlier than a date which is fourteen
(14) calendar days prior to the Closing Date;
(d) a certificate executed by each
Shareholder certifying to Purchaser (i) that all the
representations and warranties of the Shareholders and the Company
contained herein are true as of the Closing Date with the same
effect as though made at such time, except to the extent such
representations and warranties expressly relate to an earlier date,
in which case such representations and warranties are true on and
as of such earlier date, (ii) that the Shareholders and the Company
have in all material respects performed or complied with the
covenants and agreements required of the Shareholders and the
Company set forth in this Agreement to be
STOCK PURCHASE
AGREEMENT – Page
3
satisfied by the Closing Date, and
(iii) that all of the conditions contained in Article 6 have been
satisfied except those, if any, waived in writing by the
Shareholders;
(e) a certificate of the corporate
Secretary of the Company certifying to Purchaser (i) the incumbency
of the officers of the Company on the Execution Date and on the
Closing Date and bearing the authentic signatures of all such
officers who shall execute this Agreement and any additional
documents contemplated by this Agreement, and (ii) the due adoption
and text of the resolutions of the directors of the Company,
authorizing the execution, delivery and performance of this
Agreement and all ancillary documents and instruments by the
Company, and that such resolutions have not been amended or
rescinded and remain in full force and effect on the Closing
Date;
(f) releases of liens and mortgages
and UCC termination statements for any and all liens, mortgages,
security interests, restrictions and financing statements with
respect to any of the assets of the Company (other than those
exclusively relating to any of the Contracts and any Permitted
Encumbrances) by the holders of such liens or mortgages or the
secured parties named in such financing statements or written
understandings to provide same to Purchaser upon payment of the
amounts secured thereby;
(g) all consents to the change in
control of the Company from the third parties listed in Schedule
1.5(g) required to approve the change in control of the Company
(the “Contract Consents”);
(h) all governmental approvals and
authorizations that are required for the consummation of the
transactions contemplated by this Agreement (the
“Governmental Approvals”);
(i) the Asset Purchase Agreement by
and between Purchaser and Mountain State Behavioral Health
Services, LLC, a West Virginia limited liability company (the
“Asset Purchase Agreement”), and all items and
documents required to be delivered therewith; and
(j) such other instruments,
certificates, consents or other documents which are reasonably
necessary to carry out the transactions contemplated by this
Agreement and to comply with the terms hereof.
1.6 Items to be Delivered by
Purchaser at Closing . At or before the Closing, Purchaser
shall execute and deliver or cause to be delivered to the
Shareholders the following, duly executed by Purchaser where
appropriate:
(a) payment of the Closing Purchase
Price Payment on the Closing Date by wire transfer of immediately
available funds to the Shareholders to the accounts specified by
the Shareholders, which accounts the Shareholders shall specify to
Purchaser not less than three (3) business days prior to the
Closing Date in writing;
(b) a certificate of Purchaser,
executed by the President or any Vice President of Purchaser,
certifying to the Shareholders (i) that all the representations and
warranties of Purchaser contained herein are true as of the Closing
Date with the same effect as though made at such time, except to
the extent such representations and warranties expressly relate to
an
STOCK PURCHASE
AGREEMENT – Page
4
earlier date, in which case such
representations and warranties are true on and as of such earlier
date, (ii) that Purchaser has in all material respects performed or
complied with the covenants and agreements required of Purchaser
set forth in this Agreement required to be satisfied by the Closing
Date and (iii) that all of the conditions contained in Article 7
have been satisfied except those, if any, waived in writing by
Purchaser;
(c) a certificate of the corporate
Secretary of Purchaser certifying to the Shareholders (i) the
incumbency of the officers of Purchaser on the Execution Date and
on the Closing Date and bearing the authentic signatures of all
such officers who shall execute this Agreement and any additional
documents contemplated by this Agreement and (ii) the due adoption
and text of the resolutions of the directors of Purchaser
authorizing the execution, delivery and performance of this
Agreement and all ancillary documents and instruments by Purchaser,
and that such resolutions have not been amended or rescinded and
remain in full force and effect on the Closing Date;
(d) original certificate of good
standing, or comparable status, of Purchaser, issued by the West
Virginia Secretary of State dated no earlier than a date which is
fourteen (14) calendar days prior to the Closing Date;
(e) the Escrow Agreement;
(f) the Asset Purchase Agreement and
all items and documents required to be delivered
therewith;
(g) such other instruments,
certificates, consents or other documents which are reasonably
necessary to carry out the transactions contemplated by this
Agreement and to comply with the terms hereof; and
(h) the Guaranty and Suretyship
Agreement of Horizon Health Corporation attached to this Agreement
as Exhibit B (the “Parent Guaranty”).
1.7 Termination of Mountain State
Management Agreement . Notwithstanding any provision to the
contrary contained in this Agreement, the Parties agree that, as of
the Effective Time, that certain Management Agreement dated October
31, 2000 (the “Mountain State Management Agreement”) by
and between the Company and Mountain State Behavioral Health
Services, LLC (“Mountain State”) shall terminate;
provided, however , that all amounts owed by Mountain State
to the Company as of the Effective Time under the Mountain State
Management Agreement shall remain payable by Mountain
State.
STOCK PURCHASE
AGREEMENT – Page
5
1.8 Variable Payments A and B
.
(a) On or before ninety (90) days
after the end of the twelve month period described below (the
“First Variable Payment Date”), Purchaser shall make an
additional payment to the Shareholders (“Variable Payment
A”) pro rata in accordance with the percentage of the total
Shares held by each Shareholder in an amount equal to $498,778.00
subject, however, to the following adjustments:
(i) In the event that the
Contribution to EBITDA for the 12-month period commencing as of the
first day of the month after the month in which the Closing occurs
is less than $600,000.00 (the “Year 1 Existing Contract
EBITDA Target”) then Variable Payment A shall be decreased by
six times (6x) the amount that the Contribution to EBITDA for such
12-month period is less than the Year 1 Existing Contract EBITDA
Target; or
(ii) In the event that the
Contribution to EBITDA for such 12-month period is more than the
Year 1 Existing Contract EBITDA Target, then, subject to the
provisions of subsection 1.8(f) below, Variable Payment A shall be
increased by six times (6x) the amount that the actual Contribution
to EBITDA for such 12-month period is in excess of the Year 1
Existing Contract EBITDA Target.
(b) On or before ninety (90) days
after the end of the twelve month period described below (the
“Second Variable Payment Date”), Purchaser shall make
an additional payment to the Shareholders (“Variable Payment
B”) pro rata in accordance with the percentage of the total
Shares held by each Shareholder in an amount equal to $335,300.00
subject, however, to the following adjustments:
(i) In the event that the
Contribution to EBITDA for the second 12-month period commencing
after the first twelve month period referenced in Section 1.8(a)
above is less than $937,500.00 (the “Year 2 Existing Contract
EBITDA Target”) then Variable Payment B shall be decreased by
six times (6x) the amount that the actual Contribution to EBITDA
for such 12-month period is less than the Year 2 Existing Contract
EBITDA Target; or
(ii) In the event that the
Contribution to EBITDA for such 12-month period is more than the
Year 2 Existing Contract EBITDA Target, then, subject to the
provisions of subsection 1.8(f) below, Variable Payment B shall be
increased by six times (6x) the amount that the actual Contribution
to EBITDA for such 12-month period is in excess of the Year 2
Existing Contract EBITDA Target.
(c) For the purposes of this Section
1.8, the term “Contribution to EBITDA” shall mean the
operating margin earned by the Company on that certain Management
Agreement dated November 1, 2003, by and between St. Mary’s
Medical Center, Inc. and the Company for the applicable period, all
as determined by Purchaser in accordance with generally accepted
accounting principles consistently applied (“GAAP”),
including the methods and practices as historically applied by the
Company prior to the Closing and as are reflected in the unaudited
balance sheet of the Company as of April 30, 2005 (“Company
Historical GAAP”). As specified in Section 9.4, Purchaser
shall maintain its separate corporate existence until the Second
Variable Payment Date. The principles and methodologies for
determining the Contribution to EBITDA and other terms and
conditions relating to the payment of Variable Payment A and
Variable Payment B hereunder shall be as specified in Schedule
1.8 .
(d) Purchaser shall deliver to the
Shareholders its determination of the applicable Contribution to
EBITDA with each of Variable Payment A and B. The Shareholders may
dispute such determination and have such determination finally
resolved in accordance with the procedures provided in Section
1.8(e).
STOCK PURCHASE
AGREEMENT – Page
6
(e) Should the Shareholders disagree
with Purchaser’s determination of Contribution to EBITDA, the
Shareholders shall notify Purchaser within fifteen (15) days after
Purchaser’s delivery of its determination of Contribution to
EBITDA and the applicable Variable Payment to the Shareholders. In
the event that the Shareholders and Purchaser are not able to agree
on the actual Contribution to EBITDA within thirty (30) days after
the Shareholders’ delivery of notice of disagreement, the
Shareholders and Purchaser shall each have the right to require
that such disputed determination be submitted to Arnett &
Foster, PLLC, or if Arnett & Foster, PLLC is not available for
any reason or does not maintain its independent status, such other
independent certified public accounting firm as the Shareholders
and Purchaser may then promptly mutually agree upon in writing (the
“Accounting Firm”) for computation or verification in
accordance with the provisions of this Agreement. The Accounting
Firm shall review the matters in dispute and, acting as
arbitrators, shall promptly decide the proper amounts of such
disputed entries (which decision shall also include a final
calculation of Contribution to EBITDA). The submission of the
disputed matter to the Accounting Firm shall be the exclusive
remedy for resolving disputes relative to the determination of
Contribution to EBITDA. The Accounting Firm’s determination
shall be binding upon the Shareholders and Purchaser. The
Accounting Firm’s fees and expenses shall be borne equally by
the Shareholders and Purchaser.
(f) Notwithstanding any provision of
this Agreement to the contrary, the cumulative total amount of
Variable Payment A, Variable Payment B, Variable Payment C and
Variable Payment D shall be capped and not exceed Four Million Two
Hundred Fifteen Thousand Dollars ($4,215,000) in the
aggregate.
1.9 Variable Payments C and D
.
(a) Subject to the satisfaction of
the contingency described in Section 1.9(c), on or before the First
Variable Payment Date, Purchaser shall make an additional payment
to the Shareholders (“Variable Payment C”) pro rata in
accordance with the percentage of the total Shares held by each
Shareholder in an amount equal to $800,000.00 subject, however, to
the following adjustments:
(i) In the event that the
Contribution to EBITDA for the 12-month period commencing as of the
first day of the month after the month of the effective date of the
Additional Contract is less than $403,000.00 (the “Year 1
Additional Contract Contribution Target”) then Variable
Payment C shall be decreased by six times (6x) the amount that the
actual Contribution to EBITDA for such 12-month period is less than
the Year 1 Additional Contract Contribution Target; or
(ii) In the event that the
Contribution to EBITDA for such 12-month period is more than the
Year 1 Additional Contract Contribution Target, then, subject to
the provisions of subsection 1.8(f) above, Variable Payment C shall
be increased by six times (6x) the amount that the actual
Contribution to EBITDA for such 12-month period is in excess of the
Year 1 Additional Contract Contribution Target.
(b) Subject to the satisfaction of
the contingency described in Section 1.9(c), on or before the
Second Variable Payment Date, Purchaser shall make an additional
payment to the Shareholders (“Variable Payment D”) pro
rata in accordance with the percentage of the total
STOCK PURCHASE
AGREEMENT – Page
7
Shares held by each Shareholder in
an amount equal to $800,000.00 subject, however, to the following
adjustments:
(i) In the event that the
Contribution to EBITDA for the 12-month period commencing after the
first 12-month period referenced in Section 1.9(a) above is less
than $390,000.00 (the “Year 2 Additional Contract
Contribution Target”) then Variable Payment D shall be
decreased by six times (6x) the amount that the actual Contribution
to EBITDA for such 12-month period is less than the Year 2
Additional Contract Contribution Target; or
(ii) In the event that the
Contribution to EBITDA for such second 12-month period is more than
the Year 2 Additional Contract Contribution Target, then, subject
to the provisions of subsection 1.8(f) above, Variable Payment D
shall be increased by six times (6x) the amount that the actual
Contribution to EBITDA for such 12-month period is in excess of the
Year 2 Additional Contract Contribution Target.
(c) Neither Variable Payment C nor
Variable Payment D will be due or be paid by Purchaser to the
Shareholders unless the Company shall have executed and commenced
services under either the Camden Clark Memorial Hospital Management
Agreement or some other management agreement of similar form and
structure and having a term of not less than five (5) years (the
“Additional Contract”) on or prior to March 31, 2006,
in a form reasonable and acceptable to Purchaser. No Variable
Payment C or Variable Payment D shall be due if the Additional
Contract is not signed and commenced on or before March 31,
2006.
(d) For the purposes of this Section
1.9, the term “Contribution to EBITDA” shall mean the
operating margin earned by the Company on the Additional Contract
for the applicable period, all as determined by Purchaser in
accordance with Company Historical GAAP. The principles and
methodologies for determining the Contribution to EBITDA and other
terms and conditions relating to the payment of Variable Payments
hereunder shall be as specified in Schedule 1.8 .
(e) Purchaser shall deliver to the
Shareholders its determination of the applicable Contribution to
EBITDA with each Variable Payment. The Shareholders may dispute
such determination and have such determination finally resolved in
the same manner and within the same time periods as are applicable
under Section 1.8(e).
1.10 Net Assets Settlement
.
(a) As used herein, the term
“Net Assets,” as determined in accordance with Company
Historical GAAP, shall mean the current assets of the Company, less
(i) the outstanding liabilities of the Company (including the
amount of accrued paid time off liability for the employees listed
in Schedule 2.5(a) as described below), and (ii) 16% of the
amount of accrued ESL of all employees of the Company. Except as
set forth below, in the event an accounting principle, including
the methods and practices as historically applied by the Company is
not in accordance with GAAP, it shall not constitute Company
Historical GAAP for any purpose under this Agreement and shall not
be followed in the determination of Net Assets under this Section
1.10 or the determination of EBITDA of the Company under Sections
1.8 or 1.9 hereof. Notwithstanding the provisions set forth above,
the Parties understand and agree that the Company’s
historical practice of not recording accrued employee paid time off
liability,
STOCK PURCHASE
AGREEMENT – Page
8
including the accrued paid time off
liability listed in Schedule 2.5(a) relating to certain of
the Company’s employees, is not in accordance with GAAP, and
that such accrued paid time off liability shall nevertheless be
taken into account for all purposes under this Agreement, including
in connection with the determination of the Net Assets of the
Company under this Section 1.10.
(b) At least ten (10) business days
prior to the Closing, the Shareholders shall in good faith deliver
to Purchaser a reasonable estimate of Net Assets as of the end of
the most recently ended calendar month prior to the Closing Date
for which financial statements are available (“Estimated Net
Assets”) and containing reasonable detail and supporting
documents showing the derivation of such estimate. The “Net
Assets Payment” shall equal the difference between the
Estimated Net Assets and $0.00. If Estimated Net Assets exceeds
$0.00, the Net Assets Payment shall be added to the Closing
Purchase Price Payment. If Estimated Net Assets is less than $0.00,
the Closing Purchase Price Payment shall be reduced by the amount
of the Net Assets Payment. Within ninety (90) days after the
Closing, Purchaser shall deliver to the Shareholders its
determination of the Net Assets as of the Effective Time. Each
Party shall have full access to the financial books and records
pertaining to the Company to confirm or audit Net Assets
computations. Should the Shareholders disagree with
Purchaser’s determination of Net Assets, the Shareholders
shall notify Purchaser in writing within fifteen (15) days after
Purchaser’s delivery of its determination of Net Assets and
state the basis for their disagreement. If the Shareholders and
Purchaser fail to agree within thirty (30) days after the
Shareholders’ delivery of notice of disagreement on the
amount of Net Assets, such disagreement shall be resolved in
accordance with the procedures set forth in Section 1.10(c), which
shall be the sole and exclusive remedy for resolving disputes
relative to the determination of Net Assets. The Purchase Price
shall be increased or decreased based on the difference between the
actual Net Assets as of the Effective Time and the Estimated Net
Assets calculated at the Closing and, within five (5) business days
after determination thereof, any excess of actual Net Assets over
Estimated Net Assets shall be paid in cash to the Shareholders, and
any deficiency in actual Net Assets versus Estimated Net Assets
shall be paid in cash to Purchaser pursuant to the Escrow
Agreement, in either case without interest on such
amount.
(c) Dispute of Adjustments .
In the event that the Shareholders and Purchaser are not able to
agree on the actual Net Assets within thirty (30) days after the
Shareholders’ delivery of notice of disagreement in
accordance with Section 1.10(b) hereof, the Shareholders and
Purchaser shall each have the right to require that such disputed
determination be submitted to the Accounting Firm for computation
or verification in accordance with the provisions of this
Agreement. The Accounting Firm shall review the matters in dispute
and, acting as arbitrators, shall promptly decide the proper
amounts of such disputed entries (which decision shall also include
a final calculation of Net Assets). The submission of the disputed
matter to the Accounting Firm shall be the exclusive remedy for
resolving disputes relative to the determination of Net Assets. The
Accounting Firm’s determination shall be binding upon the
Shareholders and Purchaser. The Accounting Firm’s fees and
expenses shall be borne equally by the Shareholders and
Purchaser.
STOCK PURCHASE
AGREEMENT – Page
9
ARTICLE 2
REPRESENTATIONS AND WARRANTIES OF
THE SHAREHOLDERS
Except as otherwise indicated on the
applicable Disclosure Schedules expressly related to the particular
representation or warranty stated below in this Article 2, the
Shareholders hereby jointly and severally represent and warrant to
Purchaser as to the following matters as of the Execution Date.
Except as otherwise provided herein, the Shareholders shall be
deemed to remake all of the following representations and
warranties jointly and severally as of the Closing Date and the
Effective Time:
2.1 Authority . The Company
has full corporate power and authority to enter into this Agreement
and all documents required to be delivered hereunder and full
corporate power and authority to carry out and perform the
transactions contemplated herein.
2.2 Authorization/Execution .
All corporate and other actions required to be taken by the
Shareholders and the Company to authorize the execution, delivery
and performance of this Agreement, all documents executed by the
Shareholders and the Company which are necessary to give effect to
this Agreement, and all transactions contemplated hereby have been
duly and properly taken or obtained by the Shareholders and the
Company. No other corporate or other action on the part of the
Shareholders or the Company is necessary to authorize the
execution, delivery and performance of this Agreement, all
documents necessary to give effect to this Agreement and all
transactions contemplated herein. This Agreement and all documents
delivered hereunder have been duly and validly executed and
delivered by the Shareholders and the Company and, assuming due and
valid execution by, and enforceability against, Purchaser, this
Agreement and all documents delivered hereunder constitute valid
and binding obligations of the Shareholders and the Company
enforceable in accordance with their respective terms subject to
(a) applicable bankruptcy, reorganization, insolvency, moratorium
and other laws affecting creditors’ rights generally from
time to time in effect and (b) limitations on the enforcement of
equitable remedies.
2.3 Organization and Good
Standing; No Subsidiaries; No Conflicts .
(a) The Company is a corporation
duly organized, validly existing and in good standing under the
laws of the State of West Virginia. The Company has full power and
authority to own, operate and lease its properties and to carry on
its business as now conducted.
(b) The Company has no subsidiaries,
whether direct or indirect. The Company has no equity interest or
investment in, and does not have any other right or obligation to
purchase any equity interest or other investment in, and is not a
partner of or joint venturer with, any other person or
entity.
(c) Except as provided in
Schedule 2.3(c) , the execution and delivery of this
Agreement and the performance of the transactions contemplated by
this Agreement and all other instruments, agreements, and
certificates referenced herein to which the Shareholders and the
Company are or will be a Party do not (i) violate any decree or
judgment of any court or governmental authority which is applicable
to or binding upon the Shareholders or the Company; (ii) violate
any law, rule or regulation applicable to the Shareholders or the
Company; (iii) violate or conflict with, or result in a breach of,
or constitute a default (or an event which,
STOCK PURCHASE
AGREEMENT – Page
10
with or without notice or lapse of
time or both, would constitute a default) under, or permit
cancellation of, or result in the creation of any encumbrance upon
any of the assets of the Company or the Shares under, any Material
Contract, lease, sales order, purchase order, indenture, mortgage,
note, bond or license to which the Company is a Party, or by which
the Company is bound; (iv) permit the acceleration of the maturity
of any indebtedness of the Company; or (v) violate or conflict with
any provision of the Articles of Incorporation or Bylaws of the
Company.
2.4 Title to Shares . The
Shareholders are the unconditional sole legal, beneficial, record
and equitable owner of the Shares, free and clear of any and all
Encumbrances. The Shareholders have not granted and are not a party
to any agreement granting preemptive rights, rights of first
refusal or any similar or comparable rights with respect to the
Shares. At the Closing, the Shareholders will convey to Purchaser
good and valid title to the Shares, free and clear of any and all
Encumbrances.
2.5 Financial Statements;
Changes .
(a) The Shareholders have delivered
to Purchaser the unaudited balance sheets for the Company at
December 31, 2004, 2003 and 2002, and the related statements of
operations for the periods then ended. All such financial
statements have been prepared in conformity with Company Historical
GAAP applied on a consistent basis throughout such periods. Such
statements of operations present fairly in all material respects
the results of operations of the Company for the respective periods
covered, and the balance sheets present fairly in all material
respects the financial condition of the Company as of their
respective dates. Except as set forth in Schedule 2.5(a) ,
since December 31, 2004, there has been no change in any of the
significant accounting policies, practices or procedures of the
Company.
(b) The Shareholders have delivered
to Purchaser an unaudited balance sheet for the Company at April
30, 2005 (the “Interim Balance Sheet Date”) and the
related statement of operations for the four-month period then
ended. Such interim financial statements have been prepared in
conformity with Company Historical GAAP. The interim statement of
operations presents fairly in all material respects the results of
the operations of the Company for the period covered, and the
interim balance sheet presents fairly in all material respects the
financial condition of the Company at the Interim Balance Sheet
Date. Such interim financial statements reflect all adjustments
necessary for a fair presentation of the financial information
contained therein other than normal year-end adjustments which are
not material in amount in the aggregate. At the Interim Balance
Sheet Date, the Company had no material liability (actual,
contingent or accrued) that, in accordance with Company Historical
GAAP applied on a consistent basis, should have been shown or
reflected on the interim balance sheet but was not.
(c) Except as set forth in
Schedule 2.5 , since the Interim Balance Sheet Date, whether
or not in the ordinary course of business, there has not been,
occurred or arisen:
(i) any change in or event affecting
the Company or the Shareholders, that has had or would reasonably
be expected to have a Material Adverse Effect; or
(ii) any strike or other labor
dispute; or
STOCK PURCHASE
AGREEMENT – Page
11
(iii) any casualty, loss, damage or
destruction (whether or not covered by insurance) of any property
of the Company that is material or that has involved or may involve
a material loss to the Company in excess of applicable insurance
coverage.
2.6 Tax and Other Returns and
Reports . Except as set forth in Schedule 2.6
:
(a) For purposes of this Agreement,
“Tax” or “Taxes” shall be defined as set
forth below in Section 2.6(c) and shall include (i) any obligations
under any agreements or arrangements with any other Person with
respect to such amounts and including any liability for Taxes of
any predecessor or previously owned entity and (ii) any liability
for any Taxes as a result of being a member of an affiliated,
consolidated, combined or unitary group. For purposes of this
Section 2.6 and Schedule 2.6 , with respect to matters
pertaining to this Section 2.6, the terms “Company,”
“Subsidiary” and “Subsidiaries” shall
include all entities currently or previously owned, directly or
indirectly, by the Company.
(b) Tax Returns and Audits
.
(i) The Company has timely filed
(taking into account valid extensions of the time for filing) all
Tax returns required to have been filed and all such Tax returns
were true, correct and complete in all material respects. All Taxes
owed by the Company (whether or not shown on any Tax return) (A)
for all tax years of periods that ended on or before December 31,
2004 will have been timely paid in full on or prior to the Closing
Date and (B) for all tax years or periods that began prior to, on
or after December 31, 2004 and end on or before the Closing Date
and, with respect to any tax year or period beginning prior to, on
or after December 31, 2004 and ending after the Closing Date, the
portion of such taxable year or period ending on and including the
Closing Date if due and payable prior to the Closing Date, will
have been timely paid in full on or prior to the Closing Date, or
in the case of either (A) or (B) above, will have been accrued and
adequately disclosed and fully provided for on the books and
records of the Company in accordance with GAAP. The Company is not
currently the beneficiary of any extension of time within which to
file any Tax return. No claim has ever been made by an authority in
a jurisdiction where the Company does not file Tax returns that it
is or may be subject to taxation by that jurisdiction.
(ii) The Company has withheld and
paid all Taxes required to have been withheld and paid in
connection with amounts paid or owing to any employee, independent
contractor, creditor, member, or other third party.
(iii) The Company and the
Shareholders have made available (or will make available through
the date of Closing) to Purchaser (i) correct and complete copies
of all Tax returns of the Company and (ii) any examination reports,
statements of deficiencies and assessments by any governmental
authority against or agreed to by the Company since the
Company’s formation. The Company does not expect any
authority to assess additional Taxes for any period for which Tax
returns have been filed. There is no dispute or claim concerning
any Tax liability of the Company claimed, threatened or otherwise
raised by any authority. The Company has not waived any statute of
limitations in respect of Taxes or agreed to any extension of time
with respect to a Tax assessment or deficiency.
STOCK PURCHASE
AGREEMENT – Page
12
(iv) All material liabilities of the
Company for any unpaid Taxes (whether or not shown to be due on any
Tax return) have either (A) been accrued for or reserved on the
Company financial statements in accordance with GAAP or (B) with
respect to material unpaid Taxes that may have accrued since the
Interim Balance Sheet Date in connection with the operation of the
business of the Company have been recorded on the books of the
Company in the ordinary course.
(v) There are no liens or security
interests on any of the assets of the Company or the Shares that
arose in connection with any failure (or alleged failure) to pay
any Tax.
(vi) The Company has not filed any
consent agreement under Section 341(f) of the Internal Revenue Code
of 1986 (the “Code”) or agreed to have Section
341(f)(2) of the Code apply to any disposition of a subsection (f)
asset (as defined in Section 341(f)(2) of the Code) owned by the
Company. No property owned by the Company is “tax-exempt use
property” within the meaning of Section 168(h) of the Code.
The Company is not a party to any lease made pursuant to former
Section 168(f)(8) of the Internal Revenue Code of 1954.
(vii) The Company is not under any
obligation to make a payment that will not be deductible because of
the application of Sections 280G, 404, 162(m) and/or 4999 of the
Code. The Company has disclosed on its Tax returns all positions
taken therein that could give rise to a substantial understatement
(i) of federal income tax under Code Section 6662 or (ii) of any
Tax under a similar provision of state, local or foreign Tax law.
The Company has not engaged in any transaction which would be
treated as a “reportable transaction” within the
meaning of Treasury Regulations Section 1.6011-4 or otherwise been
involved in a transaction which would require it to disclose a
“reportable transaction.” The Company has not been a
member of an affiliated group filing a consolidated federal income
Tax return and does not have any liability for the Taxes of any
Person (other than the Company) under Treasury Regulations Section
1.1502-6, or any similar provision of state, local or foreign law,
as a transferee or successor, by contract, or otherwise. The
Company has not been a party to any Tax allocation or sharing
agreement. Neither the Company nor its Subsidiaries is currently or
has been a United States real property holding corporation within
the meaning of Section 897(c)(2) of the Code during the applicable
period specified in Section 897(c)(1)(A)(ii) of the
Code.
(viii) The Company is and has been
in full compliance with all terms and conditions of any Tax
exemptions, Tax holidays or other Tax reduction agreements. The
consummation of the transactions contemplated herein will not have
any material adverse effect on the continued validity and
effectiveness of any such Tax exemption, Tax holiday or other Tax
reduction agreement or order.
(ix) Neither the Company nor any of
its Subsidiaries has constituted either a “distribution
corporation” or a “controlled corporation” in a
distribution of stock qualifying for tax-free treatment under Code
Section 355 (a) in the two year prior to the date of this Agreement
or (b) in a distribution which could otherwise constitute part of a
“plan” or “series of related transactions”
(within the meaning of Code Section 355(c)).
STOCK PURCHASE
AGREEMENT – Page
13
(x) The Company has not, with
respect to any open taxable period, applied for and been granted
permission to adopt a change in its method of accounting requiring
adjustments under Section 481 of the Code or comparable state or
foreign law.
(xi) The Company is not a partner in
any entity classified as a partnership for federal income tax
purposes.
(xii) The Company has not made an
election under Treasury Regulations Section 301.7701-3 with respect
to any entity.
(xiii) The Company will not be
required to include any item of income in, or exclude any item of
deduction from, taxable income for any taxable period (or portion
thereof) ending prior to, on, or after the Closing Date as a result
of any deferred intercompany gain or any excess loss account
described in Treasury Regulations under Code Section 1502 (or any
corresponding or similar provision of federal state, local or
foreign income Tax law).
(xiv) During the time it has been in
existence, the Company has been a validly electing S corporation
within the meaning of Sections 1361 and 1362 of the Code.
Schedule 2.6 identifies each Subsidiary of the Company that
is a “qualified subchapter S subsidiary” within the
meaning of Section 1361(b)(3)(B) of the Code. Each Subsidiary so
identified has been a qualified subchapter S subsidiary at all
times from the date shown on Schedule 2.6 through the
Closing Date.
(c) “Tax” and
“Taxes” means any federal, state, local or foreign
income, gross receipts, license, payroll, employment, excise,
severance, stamp, occupation, premium, windfall profits,
environmental (including taxes under Code Section 59A), customs
duties, capital stock, franchise, profits, withholding, social
security (or similar), unemployment, disability, real property,
personal property, sales, use, transfer, registration, value added,
alternative or add-on minimum, estimated or other tax of any kind
whatsoever, including any interest, penalty, or addition thereto,
whether disputed or not.
(d) The Company shall not be liable
for any Tax under Code Section 1374 in connection with the deemed
sale of the Company’s assets (including the assets of any
qualified subchapter S subsidiary) caused by the Code Section
338(h)(10) election. Neither the Company nor any qualified
subchapter S subsidiary of the Company has, in the past 10 years,
(A) acquired assets from another corporation in a transaction in
which the Company’s tax basis for the acquired assets was
determined, in whole or in part, by reference to the Tax basis of
the acquired assets (or any other property) in the hands of the
transferor or (B) acquired the stock of any corporation that is a
qualified subchapter S subsidiary.
2.7 Contracts . Schedule
2.7 lists each contract or agreement to which the Company is a
party or to which any of its properties are subject or by which any
thereof is bound. Unless otherwise so noted in Schedule 2.7
, each such Contract was entered into in the ordinary course of
business. As used herein, “Contract” means any contract
that (a) after the Interim Balance Sheet Date obligates the Company
to pay any amount, requires the Company to perform any services or
otherwise obligates the Company in any manner, (b) has an unexpired
term as of the Interim Balance Sheet Date in excess of twelve (12)
months that is not terminable upon ninety (90) days or less notice
by the Company at any time during the term, without penalty, (c)
contains a
STOCK PURCHASE
AGREEMENT – Page
14
covenant not to compete or otherwise
significantly restricts business activities, (d) limits the ability
of the Company to conduct its business, including as to manner or
place, (e) grants a power of attorney, agency or similar authority
to another person or entity, (f) contains a right of first refusal,
(g) constitutes a collective bargaining agreement including any
collective bargaining agreement with physicians or any other
referral source, (h) constitutes an employment or severance
agreement with any director, officer or employee of the Company or
the Shareholders, (i) represents a contract upon which the business
of the Company is substantially dependent or a contract which is
otherwise material to the business of the Company, (j) represents a
contract with a physician or an immediate family member of a
physician (as that term is defined in 42 C.F.R. § 411.351) or
any other referral source, including any contract with a pharmacy
or any other supplier of medical products, (k) represents a
contract with an entity in which a referring physician (as that
term is defined in 42 U.S.C. § 1395m(h)(7)) or a referring
physician’s immediate family member has an ownership or
investment interest, (l) represents a third party payor, managed
care or preferred provider organization contract, or (m) was not
made in the ordinary course of business. True, correct and complete
copies of the Contracts and any other contracts of the Company,
including all amendments and supplements, have been made available
to Purchaser. Each Contract is valid and subsisting; except as set
forth in Schedule 2.7 , the Company has duly performed in
all material respects all its obligations thereunder to the extent
that such obligations to perform have accrued; and, except as set
forth in Schedule 2.7 , no breach or default, alleged breach
or default, or event which would (with the passage of time, notice
or both) constitute a material breach or default thereunder by the
Company (or any other party or obligor with respect thereto), has
occurred or as a result of the execution of this Agreement or its
performance will occur.
2.8 Real and Personal Property;
Title to Property; Leases . The Company does not own or lease
any real property. The Company does not lease any personal
property. All assets of the Company are listed in Schedule
2.8 .
2.9 Capitalization of the
Company . The authorized capital stock of the Company consists
of One Thousand (1,000) shares of Common Stock, $1.00 par value, of
which One Thousand (1,000) shares are validly issued and
outstanding. All such outstanding shares of capital stock of the
Company are fully paid and nonassessable. All of the issued and
outstanding shares of capital stock of the Company are owned of
record and beneficially by the Shareholders. As of the Execution
Date and immediately prior to Closing, Scott C. Stamm owns 667
shares of the Company’s Common Stock and Patrick D. Burrows
owns 333 shares of the Company’s Common Stock. The Company
has provided to Purchaser a correct and complete copy of the stock
registry and stock transfer records of the Company listing all
Shareholders of the Company and the outstanding share certificates
and total number of shares issued to each stockholder of the
Company since its inception. The Company has no other capital stock
authorized for issuance and has no treasury shares. The Company has
not purchased any shares of its capital stock from Shareholders
within the three (3) year period prior to the Execution Date. There
are no outstanding options, warrants, convertible instruments, or
other rights, agreements, or commitments to issue or acquire any
shares of common stock of the Company or any other security
constituting, or convertible or exchangeable into, capital stock of
the Company. The Company has not granted and is not a party to any
agreement granting preemptive rights, rights of first refusal, or
registration rights with respect to its outstanding or authorized
capital stock or any capital stock of the Company to be issued in
the future. The Company is not bound by any
STOCK PURCHASE
AGREEMENT – Page
15
exclusive agency or indemnity agreement
applicable to the issuance of shares of its capital stock after the
Execution Date or the Closing Date.
2.10 Intangible Property .
Schedule 2.10 lists any and all marks and other material
items of intangible property in which the Company has an interest
and the nature of such interest (the “Intangible
Property”). Except as shown in Schedule 2.10 , the
Intangible Property includes all permits or other rights with
respect to any of the foregoing. The Company has complete rights to
use or ownership of all Intangible Property required for use in
connection with the business of the Company. Except as disclosed in
Schedule 2.10 , the Company does not use any Intangible
Property by consent of any other person and is not required to and
does not make any payments to others with respect thereto. Except
as shown in Schedule 2.10 , and except for any lien for
Taxes not yet due and payable (collectively, “Permitted
Encumbrances”), the Intangible Property of the Company is
fully assignable free and clear of any encumbrances. The Company
has in all material respects performed all obligations required to
be performed by, and the Company is not in default in any material
respect under, any contract relating to any of the foregoing. The
Company has not received any notice to the effect (or otherwise has
Knowledge) that such intangible property or any use thereof by the
Company conflicts with or infringes (or allegedly conflicts with or
infringes upon) the rights of any Person.
2.11 Legal Proceedings .
Except as set forth in Schedule 2.11 , there is no order or
action pending, or, to the Knowledge of the Shareholders
threatened, against or affecting the Company, or any of its
respective properties or assets that involves a claim of aggregate
liability in excess of $25,000 against the Company. Schedule
2.11 lists each order and each action that involves claim of
aggregate liability in excess of $25,000 against, or that enjoins
or seeks to enjoin or excludes or seeks to exclude the conduct of
any activity by, the Company.
2.12 Accounting Records; Internal
Controls .
(a) Accounting Records . The
Company has records that accurately and validly reflect its
respective transactions, and accounting controls sufficient to
insure that such transactions are (i) executed in accordance with
management’s general or specific authorization and (ii)
recorded in conformity with Company Historical GAAP so as to
maintain accountability for assets.
(b) Data Processing; Access .
Such records, to the extent they contain important information that
is not easily and readily available elsewhere, have been
duplicated, and such duplicates are stored safely and securely
pursuant to procedures and techniques utilized by companies of
comparable size in similar lines of business.
2.13 Insurance . Schedule
2.13 lists all insurance policies and bonds that are maintained
by the Company and indicates the type of insurance, policy number,
term, identity of insurer, premiums and coverage amounts for the
previous five (5) years and b